Literature DB >> 6228561

Immunoregulatory cell subsets in Goodpasture's syndrome: evidence for selective T suppressor-cell depletion during active autoimmune disease.

F S Ligler, G R Westby, B C Hertz, C M Durning, R Cohen, H Bonner.   

Abstract

In a patient with documented untreated Goodpasture's syndrome, serial determination of T-cell subsets using monoclonal antibodies and flow cytometry revealed a persistent but variable deficiency of T-suppressor cells during the period of active disease. As the percentage of OKT8+ cells (suppressor/cytotoxic T cells) returned to normal levels, anti-basement membrane autoantibody production decreased and finally disappeared. Possible pathogenetic implications of immunoregulatory cell imbalance specifically in reference to Goodpasture's syndrome are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6228561     DOI: 10.1007/bf00915798

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  25 in total

1.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture's syndrome.

Authors:  W A Briggs; J P Johnson; S Teichman; H C Yeager; C B Wilson
Journal:  Medicine (Baltimore)       Date:  1979-09       Impact factor: 1.889

3.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

4.  Initial characterization of monoclonal antibodies against human monocytes.

Authors:  V Ugolini; G Nunez; R G Smith; P Stastny; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

5.  Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

Authors:  J J Twomey; A H Laughter; S Farrow; C C Douglass
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

6.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

8.  Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosus.

Authors:  L Chatenoud; M A Bach
Journal:  Kidney Int       Date:  1981-08       Impact factor: 10.612

9.  Defective suppressor cell activity in cancer patients: a defect in immune regulation.

Authors:  G W Hubbard; H Wanebo; M Fukuda; R Pace
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

10.  The monoclonality of human B-cell lymphomas.

Authors:  R Levy; R Warnke; R F Dorfman; J Haimovich
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more
  1 in total

1.  FMS-like tyrosine kinase 3 ligand treatment does not ameliorate experimental rapidly progressive glomerulonephritis.

Authors:  Joanna R Ghali; Kim M O'Sullivan; Peter J Eggenhuizen; Stephen R Holdsworth; A Richard Kitching
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.